Close Menu
healthylife7.comhealthylife7.com

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Eli Lilly’s Weight-Loss Drug Demand Is Nearly Limitless. Here’s What Comes Next for the $1 Trillion Drugmaker

    August 5, 2026

    How Sensei Porcupine Creek Redefines Golf and Personal Wellbeing

    August 5, 2026

    Cyclosporiasis cases top 10,000 amid sharp increase across 47 states, CDC says

    August 5, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Eli Lilly’s Weight-Loss Drug Demand Is Nearly Limitless. Here’s What Comes Next for the $1 Trillion Drugmaker
    • How Sensei Porcupine Creek Redefines Golf and Personal Wellbeing
    • Cyclosporiasis cases top 10,000 amid sharp increase across 47 states, CDC says
    • Bank of America spends $250 million a year on GLP
    • 556th MICO conducts multi
    • Urban living linked to slightly healthier diets but also higher overweight and obesity among adolescents in Viet Nam
    • New CDC director is confirmed, giving agency its first permanent leader in a year
    • This fitness tech founder says ignoring this one number will catch up to you by midlife
    Facebook X (Twitter) Instagram
    healthylife7.comhealthylife7.com
    • Home
    • Fitness
    • Health
    • Nutrition
    • Lifestyle
    • Conditions
    • Mental Health
    • Weight Loss
    • Wellness Tips
    Wednesday, August 5
    healthylife7.comhealthylife7.com
    Home»Health»ICYMI: Boyle Stands with Research Leaders to Oppose Cuts to Philadelphia Health Research Programs and Announce Letter Demanding Answers from Trump Administration
    Health

    ICYMI: Boyle Stands with Research Leaders to Oppose Cuts to Philadelphia Health Research Programs and Announce Letter Demanding Answers from Trump Administration

    healthylife7By healthylife7August 5, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
    ICYMI: Boyle Stands with Research Leaders to Oppose Cuts to Philadelphia Health Research Programs and Announce Letter Demanding Answers from Trump Administration
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    August 5, 2026
    Press Release

    PHILADELPHIA, PA– Congressman Brendan F. Boyle (PA-02), Ranking Member of the House Budget Committee, joined Philadelphia health research leaders to oppose the Trump Administration’s cuts to programs at Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania (Penn). Congressman Boyle also announced that, as the top Democrat on the Budget Committee, he sent a formallettertoday to Office of Management and Budget (OMB) Director Russell Vought and Agency for Healthcare Research and Quality (AHRQ) Director Roger Klein, demanding answers on these cancellations.

    Image
    repboyleathealthresearchjobspresser

    “This funding isn’t partisan, nor is it controversial. It represents exactly what our federal government should be doing, creating jobs and saving lives by funding critical medical research,” said Congressman Boyle. “As the top Democrat on the House Budget Committee, I’m using my authority to demand answers.  Hardworking Philadelphia scientists are counting on this funding. So are the patients across the country, our most vulnerable, who benefit from their work.”

    Boyle sent the letter in his capacity as Ranking Member of the House Budget Committee, which has jurisdiction over the budget process, including illegal impoundments or funding freezes

    In the letter, he demanded the detailed information needed to determine whether the terminations are illegal, pressed the Administration to identify the authority it claims in canceling these grants, and asked whether the cuts are politically motivated. Boyle also demanded to know whether the Trump Administration will commit to fully spending the funding Congress appropriated for AHRQ

    The full letter can be readhere

    In recent weeks, AHRQ cut funding for dozens of grants nationwide, including several major programs at CHOP and Penn. AHRQ has also frozen or halted funding for other research grants, often without notice

    Congressman Boyle was joined by Dr. Christopher Forrest, Professor of Pediatrics at CHOP and Scientific Director of PEDSnet; and Dr. Rachel Werner, Professor of Medicine at Penn’s Perelman School of Medicine and Research Education Core Leader at PennPORTAL. Boyle was also joined by Drs. Kit Delgado, Meeta Kerlin, and Jaya Aysola with Penn Medicine

    “Seven years ago, we started a program called PEDSnet Scholars. That program has trained 44 physicians, psychologists, and nurses who are now improving health care and improving the health and well-being of children,”said Dr. Christopher Forrest. “Our scientists have focused on conditions like kidney disease, mental health disorders like ADHD and substance use, pain, infections, high blood pressure, lung diseases like asthma and cystic fibrosis. Without this funding, this program is going to be terminated, and I thank Congressman Boyle for his leadership.”

    “Along with a number of my colleagues here today, and with the AHRQ’s support, we built a program called PORTAL, which trains clinicians to become leaders in building a healthcare system that provides better care for patients,”said Dr. Rachel Werner. “What specifically do we lose from these terminations? First, they mean fewer discoveries that can make healthcare safer and more effective. Second, they mean the immediate loss of jobs. And third, they mean losing the next generation of scientists.”

    Boyle ICYMI leaders research stands
    healthylife7
    • Website

    Related Posts

    New CDC director is confirmed, giving agency its first permanent leader in a year

    August 5, 2026

    Who is most at risk from cyclosporiasis? What to know after Michigan deaths

    August 5, 2026

    Press Release: Boyle Opposes Cuts to Philadelphia Health Research Programs, Seeks Answers from Trump Administration

    August 5, 2026
    Leave A Reply Cancel Reply

    Health
    Wellness Tips

    Eli Lilly’s Weight-Loss Drug Demand Is Nearly Limitless. Here’s What Comes Next for the $1 Trillion Drugmaker

    By healthylife7August 5, 20260

    Eli Lilly (NYSE:LLY | LLY Price Prediction) opened Wednesday’s session with a blowout second-quarter earnings report, sending shares sharply higher and cementing the drugmaker’s status as the only pharmaceutical company trading above a $1 trillion market cap. On a CNBC segment breaking down the release, anchor Joe Kernen walked viewers through the headline figures that…

    How Sensei Porcupine Creek Redefines Golf and Personal Wellbeing

    August 5, 2026

    Cyclosporiasis cases top 10,000 amid sharp increase across 47 states, CDC says

    August 5, 2026

    Bank of America spends $250 million a year on GLP

    August 5, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Fitness

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026

    What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

    July 6, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us

    Welcome to HealthyLife7.com, your trusted source for reliable health, wellness, fitness, and lifestyle information. Our mission is to help people make informed decisions about their health by providing clear, practical, and easy-to-understand content.

    At HealthyLife7.com, we believe that good health starts with the right knowledge. Whether you're looking for healthy eating tips, fitness advice, mental wellness strategies, weight management guidance, or information about common health conditions, our goal is to deliver valuable content that supports a healthier lifestyle.

    Fitness

    Eli Lilly’s Weight-Loss Drug Demand Is Nearly Limitless. Here’s What Comes Next for the $1 Trillion Drugmaker

    August 5, 2026

    How Sensei Porcupine Creek Redefines Golf and Personal Wellbeing

    August 5, 2026

    Cyclosporiasis cases top 10,000 amid sharp increase across 47 states, CDC says

    August 5, 2026
    Health

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026
    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact us
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions
    © 2026 healthylife7.com. Designed by Pro.

    Type above and press Enter to search. Press Esc to cancel.